drugset / Trial / NCT06117657
Safety and Efficacy Clinical Study of KL-HIV-Tri01 in the Treatment of HIV Infected Subjects
NaSequentialOpen-labelTreatment
Summary
This is an open- label, non- randomized, uncontrolled, dose-escalation pilot study to evaluate the safety and efficacy of KL-HIV-Tri01 injection solution in HIV infected subjects treated with HAART.
Timeline
- Start
- 2023-11-10
- Primary completion
- 2024-08-20
- Completion
- 2025-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KL-HIV-Tri01 | Gene therapy (AAV / viral vector) | 2.4e+11 vg/kg | — |
| Subject | KL-HIV-Tri01 | Gene therapy (AAV / viral vector) | 8e+11 vg/kg | — |
| Subject | KL-HIV-Tri01 | Gene therapy (AAV / viral vector) | 2.4e+12 vg/kg | — |